InVivoSIM anti-human EGFR (Cetuximab Biosimilar)
SIM0002
ApplicationsFunctional Assay, Flow Cytometry, ImmunoFluorescence, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityHuman
Overview
- SupplierBio X Cell
- Product NameInVivoSIM anti-human EGFR (Cetuximab Biosimilar)
- Delivery Days Customer7
- ApplicationsFunctional Assay, Flow Cytometry, ImmunoFluorescence, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, Neutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDCetuximab
- Concentration4-11 mg/ml
- Estimated Purity≥95% , Determined by SDS-PAGE
- HostHuman
- IsotypeIgG1
- ReactivityHuman
- Storage Instruction2°C to 8°C
- UNSPSC41116161
References
- A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity.Read this paper
- Neutrophil-activating therapy for the treatment of cancer.Read this paper
Datasheet
Related products
Product group Antibodies
References
ApplicationsFunctional Assay, Western Blot, Neutralisation/Blocking
ReactivityHuman
- SizePrice
Product group Antibodies
References
ApplicationsFunctional Assay, Flow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
ReactivityHuman
- SizePrice
Product group Antibodies
References
ApplicationsImmunoPrecipitation, Neutralisation/Blocking
ReactivityHuman
- SizePrice
Product group Antibodies
ApplicationsWestern Blot, ELISA, Neutralisation/Blocking
ReactivityHuman
- SizePrice